Abstract
The purpose of this study is to observe the effect of icariside II (ICS II) on the differentiation of human amniotic mesenchymal stem cells (hAMSCs) into dopaminergic neuron-like cells, the involvement of PI3K signaling pathway inhibitors. After identifying hAMSCs by flow cytometry, hAMSCs were induced and treated with ICS II at 10 μmol/L, 3 μmol/L, 1 μmol/L, and 0 μmol/L. hAMSCs in the LY294002+3μM ICS II group were pretreated with 20 μmol/L LY294002, a PI3K-specific inhibitor, for 1 h, and then hAMSCs were induced with 3 μmol/L ICS II. On the 21st day of induction, immunofluorescence was used to detect expression of the neuronal nuclei (NeuN), neuron-specific enolase (NSE), microtubule-associated protein-2 (MAP-2), glial fibrillary acidic protein (GFAP), and tyrosine hydroxylase (TH) antigens in each induced cell group. Western blotting was used to detect the relative protein expression of NSE, MAP-2, GFAP, and TH. ELISA was used to detect the dopamine concentration in the induction medium supernatant of each group. After 21 d of ICS II induction, immunofluorescence showed that GFAP expression was not obvious in any hAMSC group. The NeuN, NSE, MAP-2, and TH fluorescent proteins were expressed in each group. NeuN was expressed in the nucleus and cytoplasm, while NSE, MAP-2, and TH were mainly expressed in the cytoplasm. The positive cell rates of NeuN, NSE, MAP-2, and TH in the 10 μmol/L, 3 μmol/L, and 1 μmol/L ICS II groups were higher than those in the LY294002+3μM ICS II and control groups. After 21 d of induction, the Western blot results showed that the protein expression levels of NSE, MAP-2, and TH in the 10 μmol/L, 3 μmol/L, and 1 μmol/L ICS II groups were significantly higher than those in the LY294002+3μM ICS II and control groups. The MAP-2 protein expression levels in the 10 μmol/L and 3 μmol/L groups were higher than that in the 1 μmol/L group. After 21 d of induction, the dopamine concentrations in the culture supernatants of the 10 μmol/L, 3 μmol/L, and 1 μmol/L ICS II groups were higher than those in the LY294002+3μM ICS II and control groups. In our experiment, ICS II induced hAMSCs to differentiate into dopaminergic neuron-like cells, and the optimal concentration range of ICS II was 3–10 μmol/L. Moreover, the PI3K signaling pathway is involved in the above differentiation process.
Similar content being viewed by others
Data Availability
The datasets generated/analyzed during the current study are available.
Change history
28 April 2021
A Correction to this paper has been published: https://doi.org/10.1007/s11626-021-00574-6
References
Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson disease: a review. JAMA 323:548–560. https://doi.org/10.1001/jama.2019.22360
Barker RA (2014) Developing stem cell therapies for Parkinson's disease: waiting until the time is right. Cell Stem Cell 15:539–542. https://doi.org/10.1016/j.stem.2014.09.016
Cai Z, Zhou ZS, Xiang Q et al (2010) Neurobiological characteristics of human histo-amniotic mesenchymal and its effect to treat Parkinson's disease. Modle Mice 16:318–321
Chen D, Fu W, Zhuang W, Lv C, Li F, Wang X (2017) Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease. J Neurosci Res 95:907–917. https://doi.org/10.1002/jnr.23879
Chen KM, Ge BF, Ma HP, Liu XY, Bai MH, Wang Y (2005) Icariin, a flavonoid from the herb Epimedium enhances the osteogenic differentiation of rat primary bone marrow stromal cells. Pharmazie 60:939–942
Chung S, Sonntag KC, Andersson T, Bjorklund LM, Park JJ, Kim DW, Kang UJ, Isacson O, Kim KS (2002) Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. Eur J Neurosci 16:1829–1838. https://doi.org/10.1046/j.1460-9568.2002.02255.x
Dihné M, Bernreuther C, Hagel C, Wesche KO, Schachner M (2006) Embryonic stem cell-derived neuronally committed precursor cells with reduced teratoma formation after transplantation into the lesioned adult mouse brain. Stem Cells 24:1458–1466. https://doi.org/10.1634/stemcells.2005-0413
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8:315–317. https://doi.org/10.1080/14653240600855905
Fishwick KJ, Li RA, Halley P, Deng P, Storey KG (2010) Initiation of neuronal differentiation requires PI3-kinase/TOR signalling in the vertebrate neural tube. Dev Biol 338:215–225. https://doi.org/10.1016/j.ydbio.2009.12.001
Gusel'nikova VV, Korzhevskiy DE (2015) NeuN as a neuronal nuclear antigen and neuron differentiation marker. Acta Nat 7:42–47. https://doi.org/10.32607/20758251-2015-7-2-42-47
He C, Wang Z, Shi J (2020a) Pharmacological effects of icariin. Adv Pharmacol 87:179–203. https://doi.org/10.1016/bs.apha.2019.10.004
He F, Wang Y, Li Y, Yu L (2020b) Human amniotic mesenchymal stem cells alleviate paraquat-induced pulmonary fibrosis in rats by inhibiting the inflammatory response. Life Sci 243:117290. https://doi.org/10.1016/j.lfs.2020.117290
Hershey LA, Coleman-Jackson R (2019) Pharmacological management of dementia with lewy bodies. Drugs Aging 36:309–319. https://doi.org/10.1007/s40266-018-00636-7
Isgrò MA, Bottoni P, Scatena R (2015) Neuron-specific enolase as a biomarker: biochemical and clinical aspects. Adv Exp Med Biol 867:125–143. https://doi.org/10.1007/978-94-017-7215-0_9
Kim E, Hwang SU, Yoon JD, Kim H, Lee G, Hyun SH (2018) Isolation and characterization of GFAP-positive porcine neural stem/progenitor cells derived from a GFAP-CreERT2 transgenic piglet. BMC Vet Res 14:331. https://doi.org/10.1186/s12917-018-1660-4
Lazzarini R, Guarnieri S, Fulgenzi G, Mariggiò MA, Graciotti L, Martiniani M, Orciani M, Specchia N, Di Primio R (2019) Mesenchymal stem cells from nucleus pulposus and neural differentiation potential: a continuous challenge. J Mol Neurosci 67:111–124. https://doi.org/10.1007/s12031-018-1216-x
Lee JE, Lim MS, Park JH, Park CH, Koh HC (2016) S6K promotes dopaminergic neuronal differentiation through PI3K/Akt/mTOR-dependent signaling pathways in human neural stem cells. Mol Neurobiol 53:3771–3782. https://doi.org/10.1007/s12035-015-9325-9
Lili X, Wang H, Xueda L, Liu B, Zheng F, Yang N (2017) Comparison of three kinds of mesenchymal stem cells differentiating into nerve cells under co-culture induction. Chin J Tissue Eng Res 21:2714–2721
Liu T, He F, Yan J, Kuang W, Yu C (2019) Icariside II affects hippocampal neuron axon regeneration and improves learning and memory in a chronic cerebral hypoperfusion rat model. Int J Clin Exp Pathol 12:826–834
Palmer C, Liste I (2017) Stem cell-based therapies for Parkinson’s disease. In: Van Phan P (ed) Neurological regeneration. Springer, Cham, pp 83–104
Parmar M, Grealish S, Henchcliffe C (2020) The future of stem cell therapies for Parkinson disease. Nat Rev Neurosci 21:103–115. https://doi.org/10.1038/s41583-019-0257-7
Rangasamy SB, Dasarathi S, Pahan P, Jana M, Pahan K (2019) Low-dose aspirin upregulates tyrosine hydroxylase and increases dopamine production in dopaminergic neurons: implications for Parkinson's disease. J NeuroImmune Pharmacol 14:173–187. https://doi.org/10.1007/s11481-018-9808-3
Schneider RB, Iourinets J, Richard IH (2017) Parkinson's disease psychosis: presentation, diagnosis and management. Neurodegener Dis Manag 7:365–376. https://doi.org/10.2217/nmt-2017-0028
Shafit-Zagardo B, Kalcheva N (1998) Making sense of the multiple MAP-2 transcripts and their role in the neuron. Mol Neurobiol 16:149–162. https://doi.org/10.1007/bf02740642
Shetty P, Thakur AM, Viswanathan C (2013) Dopaminergic cells, derived from a high efficiency differentiation protocol from umbilical cord derived mesenchymal stem cells, alleviate symptoms in a Parkinson's disease rodent model. Cell Biol Int 37:167–180. https://doi.org/10.1002/cbin.10029
Staff NP, Jones DT, Singer W (2019) Mesenchymal stromal cell therapies for neurodegenerative diseases. Mayo Clin Proc 94:892–905. https://doi.org/10.1016/j.mayocp.2019.01.001
Tatsumi K, Isonishi A, Yamasaki M, Kawabe Y, Morita-Takemura S, Nakahara K, Terada Y, Shinjo T, Okuda H, Tanaka T, Wanaka A (2018) Olig2-lineage astrocytes: a distinct subtype of astrocytes that differs from GFAP astrocytes. Front Neuroanat 12:8. https://doi.org/10.3389/fnana.2018.00008
Teixeira FG, Carvalho MM, Panchalingam KM, Rodrigues AJ, Mendes-Pinheiro B, Anjo S, Manadas B, Behie LA, Sousa N, Salgado AJ (2017) Impact of the secretome of human mesenchymal stem cells on brain structure and animal behavior in a rat model of Parkinson's disease. Stem Cells Transl Med 6:634–646. https://doi.org/10.5966/sctm.2016-0071
Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B (2010) The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol 11:329–341. https://doi.org/10.1038/nrm2882
Yan ZJ, Zhang P, Hu YQ, Zhang HT, Hong SQ, Zhou HL, Zhang MY, Xu RX (2013) Neural stem-like cells derived from human amnion tissue are effective in treating traumatic brain injury in rat. Neurochem Res 38:1022–1033. https://doi.org/10.1007/s11064-013-1012-5
Zhang Y, Huang R, Wu L, Wang Y, Jin T, Liang Q (2020) The complete chloroplast genome of Epimedium brevicornu Maxim (Berberidaceae), a traditional Chinese medicine herb. Mitochondrial DNA B 5:588–590. https://doi.org/10.1080/23802359.2019.1710593
Zhu B, Caldwell M, Song B (2016) Development of stem cell-based therapies for Parkinson's disease. Int J Neurosci 126:955–962. https://doi.org/10.3109/00207454.2016.1148034
Funding
This work was supported by Guizhou Provincial Science and Technology Foundation (Qian ke he LH zi [2015] 7475) and the Science and Technology Project of Zunyi City (Zun shi ke he HZ zi [2019] 60).
Author information
Authors and Affiliations
Contributions
Conceptualization: CY. Methodology: WK, QW and TL. Software: FH. Validation and resources: TL, LY, and CY. Data curation: TL, WK. Writing—original draft preparation: FH and TL. Writing—review and editing: TL, FH, and CY. Supervision and project administration: CY and TL. Funding acquisition: CY.
Corresponding author
Ethics declarations
Not applicable.
Conflict of interest
The authors declare no competing interests.
Additional information
Editor: Tetsuji Okamoto
The original version of this article was revised: The last word of the title of this article (“cells”) was missing in the article as originally published.
Wei Kuang and Tao Liu contributed equally to the work.
Rights and permissions
About this article
Cite this article
Kuang, W., Liu, T., He, F. et al. Icariside II promotes the differentiation of human amniotic mesenchymal stem cells into dopaminergic neuron-like cells. In Vitro Cell.Dev.Biol.-Animal 57, 457–467 (2021). https://doi.org/10.1007/s11626-021-00556-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-021-00556-8